logo inner

Senior Product Manager of Hematology Marketing

ArcellxRedwood City, California, United StatesOnsite

Who We Are


Arcellx isa public, clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherapies for patients with cancer and other incurable diseases. We believe that cell therapies are one of the forward pillars of medicine and our mission is to destroy cancer and advance humanity by developing cell therapies that are safer, more effective, and more broadly accessible.Our team members are made up of talented innovators and dreamers working from our offices in Rockville, Maryland, and Redwood City, California.

At Arcellx, we hire exceptional people and create a fun, diverse, supportive, and informal environment that allows everyone to do their best work.

What Matters to Us


Living our core values is essential to maintaining a work environment that is high-performing, inclusive, and collaborative. We look for candidates who demonstrate strong values alignment and bring different backgrounds, viewpoints, and abilities to the team.Arcellx Core Values

  • Character: Committed to always doing what’s right.
  • Audacity: Willing to challenge convention and share candid feedback with others.
  • Determination: Curious and self-motivated. Always looking to improve and learn.  
  • Collaboration: "No job is too small" mentality. Humble and willing to help others.
  • Originality: Will bring your unique perspective to the table and respect a diverse set of views and backgrounds.

How You’ll Make a Difference


As a Senior Product Manager of Hematology Marketing, you’ll use your expertise and experience in developing and executing marketing campaigns to ensure a successful launch of anitocabtagene autoleucel (anito-cel), our lead CAR T candidate for the treatment of patients with relapsed refractory multiple myeloma.In this role, you’ll be an essential member of the core cross-functional commercial launch team, the joint marketing and launch team with our commercialization partner, Kite Pharma, and of the Arcellx brand marketing team that is responsible for developing the pre- and post- launch plan for anito-cel.

Importantly, you’ll also play a major role in ensuring anito-cel is delivered to multiple myeloma patients in need of more options in their treatment journey.

The “Fine Print” – What You’ll Do


  • Support development and lead execution of priority tactical plans to support product launch and potential new indications.
  • Bring strategies to life through the development and approval of core promotional messaging, creative and materials, and execution of HCP tactics, to drive brand and launch readiness goals.
  • Manage detailed tactical plans, project timelines, marketing budget, SOWs, POs, contracts, and all key deliverables aligned to effective launch readiness with a high degree of accuracy.
  • Effectively translate primary and secondary data into insight-driven decision-making and actionable strategies and tactics to establish and sustain a competitive marketplace advantage.
  • Manage key vendor and agency relationships, including the promotional agency of record.
  • Lead Arcellx presence and participation in key congresses such as ASCO and ASH.
  • Foster trust and collaborate effectively with internal cross functional stakeholders, including the broader marketing team, sales, regulatory, medical, and legal teams, and partner closely with key stakeholders from our co-commercialization partner.
  • Leads approval process for marketing materials through internal promotional review process including management reviews and Med-Legal-Reg, and final production.

Skills and Experience We Look For


  • Bachelor’s degree is required; an advanced degree is preferred.
  • 5+ years of pharma/biotech US marketing experience. Candidates with more experience may be considered at the Associate Director level.
  • Oncology/hematology marketing and/or relevant therapeutic areas experience highly preferred.
  • Recent launch experience in cellular therapies, Hematology, Immuno-Oncology, targeted therapies, or personalized medicine highly preferred.
  • Prior joint venture/co-promote/co-marketing alliance experience preferred.
  • Strong understanding of the legal and regulatory environment in pharmaceutical promotions and compliance-related issues.
  • Proven ability to effectively work cross-functionally and influence key stakeholders, juggle multiple projects and exercise sound judgment under tight timelines, formulate, develop, and execute strategy, and thrive in ambiguity with an entrepreneurial mindset and a track record of results.
  • Ability to travel domestically up to 25%.

Rewards at Arcellx


Our people are our greatest asset, and supporting their well-being is an essential part of delivering on our mission and impacting the lives of patients. Putting this belief into practice means offering strong compensation and benefits.The base salary range for this position is $170,000 - $190,000 per year. Where a candidate falls within that range is determined by factors such as years of experience. Our compensation package also includes an annual bonus based on company goals and an equity (RSU) grant.

We do offer relocation assistance for roles if required.Our market-leading benefits package includes: 100% coverage for medical, dental and vision for team members and dependents, unlimited vacation, a 3-day weekend every month, fully-paid parental leave for up to 6 months, tuition reimbursement, 401k employer contribution and more. 

Join us in our quest to reimagine cell therapy and destroy cancer. For more on our technology, culture, and team, go to


www.arcellx.com


.


 #LI-Onsite

Life at Arcellx

Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases. The Company's proprietary ARC-sparX platform separates the tumor-recognition and tumor-killing functions of conventional CAR-T cell therapies: (1) sparX (soluble protein antigen-receptor X-linkers) proteins recognize and bind specific antigens on diseased cells and flag those cells for destruction; and (2) ARC-T (Antigen Receptor Complex-T) cells bind the sparX proteins and kill the flagged cells. Arcellx has developed a collection of sparX proteins that bind different cell surface antigens. Administration of alternate sparX proteins can redirect ARC-T cells to different disease antigens to potentially address relapsed and refractory disease due to tumor heterogeneity or antigen escape. Additionally, ARC-T cell activity can be curbed as needed by controlling the dose and frequency of sparX administration.
Your tracker settings

We use cookies and similar methods to recognize visitors and remember their preferences. We also use them to measure ad campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy or Privacy Policy.

By tapping `Accept`, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.

logo innerThatStartupJob
Discover the best startup and their job positions, all in one place.
Copyright © 2024